All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [ 177 Lu]Lu-PSMA-radioligand will be successful.

MLA

Bogsrud, Trond Velde, et al. “All That Glitters Is Not Gold: High Uptake on PSMA PET in Non-Prostate Cancers Does Not Mean That Treatment with [ 177 Lu]Lu-PSMA-Radioligand Will Be Successful.” EJNMMI Research, vol. 14, no. 1, Oct. 2024, p. 95. EBSCOhost, https://doi.org/10.1186/s13550-024-01156-9.

APA

Bogsrud, T. V., Engelsen, O., Lu, T. T. T., Stensvold, A., Johnson, D. R., Burkett, B. J., Kendi, A. T., Pandey, M. K., Sundset, R., & Durski, J. M. (2024). All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [ 177 Lu]Lu-PSMA-radioligand will be successful. EJNMMI Research, 14(1), 95. https://doi.org/10.1186/s13550-024-01156-9

Chicago

Bogsrud, Trond Velde, Ola Engelsen, Thuy Thu Thi Lu, Andreas Stensvold, Derek R Johnson, Brian J Burkett, Ayse Tuba Kendi, Mukesh K Pandey, Rune Sundset, and Jolanta M Durski. 2024. “All That Glitters Is Not Gold: High Uptake on PSMA PET in Non-Prostate Cancers Does Not Mean That Treatment with [ 177 Lu]Lu-PSMA-Radioligand Will Be Successful.” EJNMMI Research 14 (1): 95. doi:10.1186/s13550-024-01156-9.